1. Home
  2. Syndicated Research

  3. Cell Line Development North America Revenue Share 2019

Cell Line Development Market

Cell Line Development Market: Reagents and Media Segment Anticipated to be the Most Attractive During the Forecast Period: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028

Ask The Analyst Customization Available Request Methodology

60% revenue contribution of leading manufacturers

Companies like GE Healthcare, Thermo Fischer Scientific, Inc., Danaher and Merck KGaA have promising revenue share in cell line development market. These companies are endeavoring to launch novel product line in cell line development market. Companies operating in cell line development market are focusing on merger and acquisition strategies to expand their portfolio in cell line development. To expand in the cell line development market, the companies are working in collaboration with local wholesalers and distributors. In cell line development market, the local companies are contending based on pricing and effective channel management in the cell line development market.

Government organizations focusing more on drug discovery and development

In the search of new treatment pathway for the diseases like cancer and neurological disorder, researcher are focusing on cell biology and in-vitro cell culture. Furthermore government activities pertaining to development of biologics, and vaccines and growing awareness relating to monoclonal antibodies application in oncology, auto-immune diseases are expected to drive the growth of provincial business in cell line development market. In developing countries several government initiatives such as improvement in healthcare infrastructure and launch of public healthcare programs leads the growth of biotechnology sector thereby boosting the growth cell line development market

Regenerative medicines – the next generation treatment solution

Regenerative medicines deals with the process to regrow, repair and replace damaged and diseased cells, tissues, and organs which has been lost due to age, disease, damage, or congenital defects. Regenerative medicines are the next generation treatment solution and Cell Line Development is an invariable part of regenerative medicine. For example stem cells are used as a tool in regenerative medicines. Adult stem cells are easily available in human body and are used to stem cells to repair itself. Adult stem cells can be collected from cord blood, bone marrow, dental pulp and other sources. Thus, the introduction of novel product line in regenerative medicine segment is anticipate to increase the demand for cell line development during the forecast period.

cell line development market

Increasing demand for biopharmaceuticals

Biopharmaceuticals therapeutic drugs are manufactured through genetic manipulation of organism or living cells. Additionally patent expiry of branded therapeutics leads to increase in development of biosimilars thereby increase the revenue opportunity in overall cell line development market. The growing use of biological therapeutics in treating chronic diseases, like cancer, arthritis diabetes and rare diseases are majorly influencing the development of biopharmaceuticals. Additionally, the appearance of high-expressing cell lines is further boosting the growth of cell line development market.

Increasing focus on cancer research

Cell based assay involving in vitro cancer cell culture are required for cancer research and development activities. National Cancer Institute (NCI) alongside different organizations invests in R&D activities to encourage and bolster the cancer research. For example, Cancer Moonshot, The RAS Initiative, National Clinical Trials Network (NCTN), NCI Community Oncology Research Program (NCORP), NCI Genomic Data Commons (GDC) and so on. Such government and non-government organization’s initiatives on cancer research positively impacting the Cell Line Development Market.

Increase in outsourcing by pharmaceutical and biotechnological companies

The biotechnological and pharmaceutical companies are focusing on outsourcing their research and development operation to different contract research organizations (CROs). The rising global cost pressure on governments for cost effective biopharmaceuticals and changing political scenario across the globe forced these companies to take engaged into development of novel, cost effective biological products. Moreover various CROs are predominantly using in-vitro cell culture to increase the production of biologics and biopharmaceuticals which is anticipate to increase the demand for cell line development market. Cell Line Development market would pre-dominated by biopharmaceutical contract manufacturing companies. Both industrial and research verticals are in search of better and advanced cell lines to develop novel therapeutic proteins, drugs, vaccines, and biosimilars. This has led to a better prospect for growth of cell line development market over the forecast period.

Competitive Landscape

Competition section of the cell line development market features profiles of key players operating in the cell line development market based on company shares, differential strategies, cell line development product offerings, marketing approach and company dashboard. Some of the key players featured in this report include Danaher Corporation, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., Lonza (Sartorius Stedim Biotech S.A.), Merck KGaA, American Type Culture Collection (ATCC), WuXi Biologics, Selexis SA.

Lonza (Sartorius Stedim Biotech S.A.) offers a range of products for cell line development, which include culture media & reagents, primary and stem cells and CellBio Services. Selexis SA has CHO-K1 cell line in their product cell line development portfolio

The key manufacturers of cell line development are focusing on novel marketing strategies to increase product penetration. Most of the companies are focusing on acquisitions, mergers, expansion, launches and agreements as the key strategies increase the sale of their cell line products in different geographies.

Definition

Cell Line Development is the procedure by which cells are developed under controlled conditions, for the most part outside their common habitat. Cell line development have variety of application in healthcare and life science industry such as drug screening, drug development, production of bio production

About the Report

Research study have been conducted on cell line development market size for the forecast period 2018 to 2028. The cell line development market report offers a comprehensive evaluation of the business opportunities prevailing in the cell line development market along with insights on the trend, market dynamics, cell line development market size opportunity analysis and cell line development market competition. The report elaborates on the macroeconomic factors influencing the dynamics of cell line development market and its futuristic potential of cell line development.

Segmentation

The report offers a comprehensive taxonomy of cell line development market based on product type, source type, end user, type of cell line and region. Cell line development products includes media and reagents, equipment and accessories. Cell lines can be derived from mammalian cell lines and non-mammalian cell lines as well. There are various cell lines available in the cell line development market such as Recombinant cell lines, hybridomas, continuous cell lines and primary cell lines. End-use segments in cell line development market which are a part of this cell line development market report include biopharmaceutical companies, contract research organizations, academics and research institutes and biotechnology companies. The cell line development market has been analyzed across regions of North America, Latin America, Europe, CIS and Russia, Asia Pacific Excluding Japan, Japan and MEA.

Additional Questions Answered

Some of the additional questions addressed in this report on cell line development market-

  • What is the revenue potential of care cell line development market size across regions of North America and Europe?

  • Who are the key competitors and what are their portfolios in cell line development market?

  • What are major challenges influencing the growth of cell line development market?

  • How intervention from regulatory authority is shaping the cell line development market growth?

Research Methodology

The cell line development market has been estimated based on supply-demand approach. A triangulation methodology is adopted to derive the market size, which is primarily based on overall expenditure on life science research and R&D funding to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study on cell line development market also includes top trends and macro as well as micro economic factors shaping the cell line development market. With this approach, the report on cell line development market anticipates the industry attractiveness of every major segment in cell line development over the forecast period.

A recent market study published by FMI – “Cell Line Development Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the Cell Line Development market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the Cell Line Development market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the Cell Line Development market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Cell Line Development market in the most comprehensive way for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the Cell Line Development market report, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Cell Line Development market.

Chapter 2 – Market Introduction

Readers can find detailed taxonomy and the definition of the Cell Line Development market in this chapter, which helps readers to understand the basic information about the Cell Line Development market dynamics, supply chain, list of key distributor and suppliers, list of key market participants included in the report.

Chapter 3 – Global Cell Line Development Market Opportunity Analysis

This chapter explains how the Cell Line Development market will grow across various geographic regions, such as North America, Latin America, Europe, CIS and Russia, Asia-Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

Chapter 4 – Global Economic Outlook

This chapter explains how the global economic factors such as expenditure on health by country, global healthcare expenditure, political scenario, economic scenario and business environment can impact the cell line development market.

Chapter 5 – Market Background

Readers can find value chain of the market along with market dynamics including drivers, restraints, market opportunity and market trend.

Chapter 6 – Key Inclusions

Here in this chapter the report describes the regulatory scenario of cell line development market.

Chapter 7 – North America Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the North America Cell Line Development market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis. 

Chapter 8 – Europe Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Europe Cell Line Development market along with the country-wise assessment including the U.K., EU-4, Benelux and Rest of Europe. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 9 – CIS & Russia Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter explains the historical (2013-2017) and forecast (2018-2028) cell line development market in CIS & Russia by product, source type, cell type and end user, market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 10 – Latin America Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Latin America Cell Line Development market along with the country-wise assessment including Brazil, Mexico and Rest of Latin America. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis. 

Chapter 11 – Asia-Pacific Excluding Japan Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Asia-Pacific Excluding Japan Cell Line Development market along with the country-wise assessment including Greater China, India, ASEAN, South Korea and Rest of APEJ. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 12 – Japan Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter explains the historical (2013-2017) and forecast (2018-2028) cell line development market in Japan by product, source type, cell type and end user, market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 13 – Middle East and Africa Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Middle East and Africa Cell Line Development market along with the country-wise assessment including GCC Countries, South Africa and Rest of MEA. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 14 – Forecast Factors: Relevance and Impact

This chapter explains the impact of different forecast factors in cell line development market.

Chapter 15 – Cell Line Development Market: Forecast Assumptions

This chapter explains the impact of different factors on cell line development market size and its relative weightage.

Chapter 16 – Cell Line Development Market: Market Structure Analysis

In this chapter readers can find detailed description of market structure by tier, market share analysis (2017) for top players, by region and product intensity mapping by key manufacturer.

Chapter 17 – Competition Analysis

This chapter includes competition dashboard, competition benchmarking, profitability and gross margin analysis by competition and company profile of key players.

Chapter 18 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 by Region

This chapter includes detailed analysis of the growth of the global Cell Line Development market along with the regional assessment including North America, Europe, CIS & Russia, Latin America, Asia Pacific Excluding Japan, Japan, Middle East and Africa. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis by region.

Chapter 19 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 By Product

Based on the product type, the Cell Line Development market is segmented into Media and Reagents, Equipment and Accessories. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis based on the product type.

Chapter 20 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 By Source Type

Based on the source type, the Cell Line Development market is segmented into mammalian cell line and non-mammalian cell line. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis based on the source type.

Chapter 21 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 By End User

Based on the end user type, the Cell Line Development market is segmented into Biopharmaceutical Companies, Contract Research Organizations, Academics and Research Institutes and Biotechnology Companies. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis by the end user.

Chapter 22 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 by Type of Cell Lines

Based on the cell line type, the Cell Line Development market is segmented into Recombinant cell lines, Hybridomas, Continuous cell lines and Primary cell lines. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis by type of cell line.

Chapter 23 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

This chapter includes market value analysis by all segment, year on year growth analysis by all segment and absolute $ opportunity

Chapter 24 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 25 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Cell Line Development market.

Cell Line Development Market Reports - Table of Contents

  1. Executive Summary

    • Market Overview

    • Market Analysis

    • FMI Analysis and Recommendations

    • Wheel of Fortune

  2. Market Introduction

    • Market Taxonomy

    • Market Definition

  3. Global Cell Line Development Market Opportunity Analysis

    • Macro-Economic Factors

    • Opportunity Analysis

  4. Global Economic Outlook

    • Gross Domestic Product by Region & Country, 2006 – 2021

    • Global Healthcare Market Indicators

  5. Market Background

    • Value Chain Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Trends

  6. Key Inclusions

    • Regulatory Landscape

  7. North America Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

      • U.S.

      • Canada

    • Market Value (US$ Mn) Forecast By Country, 2018–2028

      • U.S.

      • Canada

    • Historical Market Value (US$ Mn) Analysis By Product Type, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By Source type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By type of Cell Lines, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By type of Cell Lines, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product

      • By Source

      • By End User

      • By Cell Line

    • Key Market Participants – Intensity Mapping

    • Drivers and Restraints: Impact Analysis

  8. Europe Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

      • EU-4

      • UK

      • BENELUX

      • Rest of Europe

    • Market Value (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Value (US$ Mn) Analysis By Product Type, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By Source type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By type of Cell Lines, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By type of Cell Lines, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product

      • By Source

      • By End User

      • By Cell Line

    • Key Market Participants – Intensity Mapping

    • Drivers and Restraints: Impact Analysis

  9. CIS & Russia Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Value (US$ Mn) Analysis By Product Type, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By Source type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By type of Cell Lines, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By type of Cell Lines, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product

      • By Source

      • By End User

      • By Cell Line

    • Key Market Participants – Intensity Mapping

    • Drivers and Restraints: Impact Analysis

  10. Latin America Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

      • Brazil

      • Mexico

      • Rest of Latin America

    • Market Value (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Value (US$ Mn) Analysis By Product Type, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By Source type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By type of Cell Lines, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By type of Cell Lines, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product

      • By Source

      • By End User

      • By Cell Line

    • Key Market Participants – Intensity Mapping

    • Drivers and Restraints: Impact Analysis

  11. Asia-Pacific Excluding Japan Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

      • Greater China

      • India

      • ASEAN

      • South Korea

      • Rest of APEJ

    • Market Value (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Value (US$ Mn) Analysis By Product Type, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By Source type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By type of Cell Lines, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By type of Cell Lines, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product

      • By Source

      • By End User

      • By Cell Line

    • Key Market Participants – Intensity Mapping

    • Drivers and Restraints: Impact Analysis

  12. Japan Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Value (US$ Mn) Analysis By Product Type, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By Source type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By type of Cell Lines, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By type of Cell Lines, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product

      • By Source

      • By End User

      • By Cell Line

    • Key Market Participants – Intensity Mapping

    • Drivers and Restraints: Impact Analysis

  13. Middle East and Africa Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

      • GCC Countries

      • South Africa

      • Rest of MEA

    • Market Value (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Value (US$ Mn) Analysis By Product Type, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By Source type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source type, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Historical Market Value (US$ Mn) Trend Analysis By type of Cell Lines, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By type of Cell Lines, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product

      • By Source

      • By End User

      • By Cell Line

    • Key Market Participants – Intensity Mapping

    • Drivers and Restraints: Impact Analysis

  14. Forecast Factors: Relevance and Impact

  15. Forecast Assumptions

  16. Market Structure Analysis

    • Market Structure by Tier

    • Market Share Analysis (2017) for Top Players, By Region

    • Product Intensity Mapping by Key Manufacturer

  17. Competition Analysis

    • Competition Dashboard

    • Competition Benchmarking

    • Profitability and Gross Margin Analysis By Competition

    • Company Profile

      • Thermo Fischer Scientific, Inc.

      • GE Healthcare

      • Merck KGaA

      • Lonza (Sartorius Stedim Biotech S.A.)

      • Danaher

      • Corning Incorporated

      • WuXi Biologics

      • Selexis SA

      • American Type Culture Collection (ATCC)

  18. Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 By Region

    • Introduction / Key Findings

    • Historical Market Value (US$ Mn) Analysis By Region

      • North America

      • Europe

      • CIS & Russia

      • Latin America

      • Asia Pacific Excluding Japan

      • Japan

      • Middle East and Africa

    • Market Value (US$ Mn) Forecast By Region

    • Market Attractiveness Analysis By Region

  19. Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028, By Product

    • Introduction/Key Finding

    • Historical Market Value (US$ Mn) Analysis By Product, 2013-2017

      • Reagent and Media

      • Equipment

      • Accessories and consumables

    • Market Value (US$ Mn) Forecast By Product, 2018–2028

    • Market Attractiveness Analysis By Product

  20. Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028, By Source Type

    • Introduction/Key Finding

    • Historical Market Value (US$ Mn) Analysis By Source Type, 2013-2017

      • Mammalian cell line

      • Non-mammalian cell line

    • Market Value (US$ Mn) Forecast By Source Type, 2018–2028

    • Market Attractiveness Analysis By Source Type

  21. Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028, By End User

    • Introduction/Key Finding

    • Historical Market Value (US$ Mn) Analysis By End User, 2013-2017

      • Biopharmaceutical Companies

      • Contract Research Organizations

      • Academics and Research Institutes

      • Biotechnology Companies

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Market Attractiveness Analysis By End User

  22. Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028, By type of Cell Lines

    • Introduction/Key Finding

    • Historical Market Value (US$ Mn) Analysis By End User, 2013-2017

      • Recombinant cell lines

      • Hybridomas

      • Continuous cell lines

      • Primary cell lines

    • Market Value (US$ Mn) Forecast By End User, 2018–2028

    • Market Attractiveness Analysis By End User

  23. Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

    • Market Value Analysis By All Segment

    • Y-o-Y Growth Analysis By All Segment

    • Absolute $ Opportunity

  24. Assumptions and Acronyms Used

  25. Research Methodology

Cell Line Development Market Reports - List of Tables

  1. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  2. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  3. North America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  4. North America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product

  5. North America Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source Type

  6. North America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  7. North America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Cell Lin

  8. North America Cell Line Development Market Participants Presence (Intensity Mapping)

  9. Europe Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  10. Europe Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  11. Europe Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source Type

  12. Europe Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application

  13. Europe Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  14. Europe Cell Line Development Market Participants Presence (Intensity Mapping)

  15. CIS & Russia Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028

  16. CIS & Russia Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product T

  17. CIS & Russia Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source Type

  18. CIS & Russia Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  19. CIS & Russia Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Cell Line

  20. CIS & Russia Cell Line Development Market Participants Presence (Intensity Mapping)

  21. Latin America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  22. Latin America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product

  23. Latin America Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source Type

  24. Latin America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Applicat

  25. Latin America Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  26. Latin America Cell Line Development Market Participants Presence (Intensity Mapping)

  27. APEJ Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  28. APEJ Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  29. APEJ Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source Type

  30. APEJ Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application

  31. APEJ Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  32. APEJ Cell Line Development Market Participants Presence (Intensity Mapping)

  33. Japan Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028

  34. Japan Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  35. Japan Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source Type

  36. Japan Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  37. Japan Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Cell Line Type

  38. Japan Cell Line Development Market Participants Presence (Intensity Mapping)

  39. Middle East and Africa Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By

  40. Middle East and Africa Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By

  41. Middle East and Africa Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source

  42. Middle East and Africa Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By

  43. Middle East and Africa Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By

  44. Middle East and Africa Cell Line Development Market Participants Presence (Intensity Mapping)

  45. Global Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region

  46. Global Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  47. Global Cell Line Development Market Volume Analysis 2013-2017 and Forecast 2018-2028, By Source Type

  48. Global Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Application

  49. Global Cell Line Development Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

Cell Line Development Market Reports - List of Figures

  1. Global Healthcare Expenditure in US$ Tn (2013–2020) 

  2. United States Funding for Stem Cell research from 2009 – 2017 

  3. North America Cell Line Development Market Value Share, By Country 

  4. North America Cell Line Development Market Value Share (2017A), By Product Type 

  5. North America Cell Line Development Market Value Share (2017A), By Source Type 

  6. North America Cell Line Development Market Value Share (2017A), By End User 

  7. North America Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  8. North America Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  9. North America Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028 

  10. North America Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2018-2028 

  11. U.S. Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  12. U.S. Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  13. Canada Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  14. Canada Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-20 28

  15. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  16. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  17. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  18. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  19. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  20. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  21. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  22. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  23. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  24. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  25. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  26. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  27. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  28. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gro wth (%), 2018-2028

  29. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  30. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y G rowth (%), 2018-2028

  31. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  32. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  33. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  34. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  35. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  36. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  37. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  38. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  39. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  40. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  41. North America Cell Line Development Market Attractiveness Analysis, By Country 

  42. North America Cell Line Development Market Attractiveness Analysis, By Source Type 

  43. North America Cell Line Development Market Attractiveness Analysis, By Product Type 

  44. North America Cell Line Development Market Attractiveness Analysis, By End User 

  45. North America Cell Line Development Market Attractiveness Analysis, By Type of Cell Lines 

  46. Europe Cell Line Development Market Value Share, By Country 

  47. Europe Cell Line Development Market Value Share (2017A), By Product Type 

  48. Europe Cell Line Development Market Value Share (2017A), By Source Type 

  49. Europe Cell Line Development Market Value Share (2017A), By End User 

  50. Europe Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  51. Europe Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  52. Europe Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028 

  53. Europe Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2018-2028 

  54. EU-4 Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  55. EU-4 Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  56. UK Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  57. UK Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  58. Benelux Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  59. Benelux Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2 28

  60. Rest of Europe Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-202 7

  61. Rest of Europe Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  62. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  63. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  64. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  65. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  66. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  67. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  68. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  69. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  70. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  71. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  72. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  73. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  74. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  75. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gro wth (%), 2018-2028

  76. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  77. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y G rowth (%), 2018-2028

  78. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  79. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  80. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  81. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  82. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  83. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  84. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  85. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  86. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  87. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  88. Europe Cell Line Development Market Attractiveness Analysis, By Country 

  89. Europe Cell Line Development Market Attractiveness Analysis, By Source Type 

  90. Europe Cell Line Development Market Attractiveness Analysis, By Product Type 

  91. Europe Cell Line Development Market Attractiveness Analysis, By End User 

  92. Europe Cell Line Development Market Attractiveness Analysis, By Type of Cell Lines 

  93. CIS & Russia Cell Line Development Market Value Share (2017A), By Product Type 

  94. CIS & Russia Cell Line Development Market Value Share (2017A), By Source Type 

  95. CIS & Russia Cell Line Development Market Value Share (2017A), By End User 

  96. CIS & Russia Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  97. CIS & Russia Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  98. CIS & Russia Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028 

  99. CIS & Russia Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2018-2028 

  100. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  101. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  102. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  103. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  104. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  105. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  106. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  107. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  108. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  109. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  110. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  111. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  112. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  113. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gr owth (%), 2018-2028

  114. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  115. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  116. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  117. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%) , 2018-2028

  118. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  119. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  120. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  121. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  122. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  123. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  124. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  125. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  126. CIS & Russia Cell Line Development Market Attractiveness Analysis, By Source Type 

  127. CIS & Russia Cell Line Development Market Attractiveness Analysis, By Product Type 

  128. CIS & Russia Cell Line Development Market Attractiveness Analysis, By End User 

  129. CIS & Russia Cell Line Development Market Attractiveness Analysis, By Type of Cell Lines 

  130. Latin America Cell Line Development Market Value Share, By Country 

  131. Latin America Cell Line Development Market Value Share (2017A), By Product Type 

  132. Latin America Cell Line Development Market Value Share (2017A), By Source Type 

  133. Latin America Cell Line Development Market Value Share (2017A), By End User 

  134. Latin America Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  135. Latin America Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  136. Latin America Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-202 8

  137. Latin America Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2018-2028 

  138. Brazil Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  139. Brazil Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2 28

  140. Mexico Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  141. Mexico Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2 28

  142. Rest of LA Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  143. Rest of LA Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 20 18-2028

  144. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  145. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  146. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  147. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  148. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  149. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  150. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  151. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  152. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  153. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  154. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  155. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  156. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  157. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gr owth (%), 2018-2028

  158. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  159. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  160. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  161. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%) , 2018-2028

  162. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  163. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  164. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  165. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  166. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  167. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  168. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  169. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  170. Latin America Cell Line Development Market Attractiveness Analysis, By Country 

  171. Latin America Cell Line Development Market Attractiveness Analysis, By Source Type 

  172. Latin America Cell Line Development Market Attractiveness Analysis, By Product Type 

  173. Latin America Cell Line Development Market Attractiveness Analysis, By End User 

  174. Latin America Cell Line Development Market Attractiveness Analysis, By Type of Cell Lines 

  175. APEJ Cell Line Development Market Value Share, By Country 

  176. APEJ Cell Line Development Market Value Share (2017A), By Product Type 

  177. APEJ Cell Line Development Market Value Share (2017A), By Source Type 

  178. APEJ Cell Line Development Market Value Share (2017A), By End User 

  179. APEJ Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  180. APEJ Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  181. APEJ Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028 

  182. APEJ Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2018-2028 

  183. Greater China Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  184. Greater China Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  185. India Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  186. India Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-20 28

  187. ASEAN Countries Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  188. ASEAN Countries Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (% ), 2018-2028

  189. South Korea Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  190. South Korea Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2 018-2028

  191. Rest of APEJ Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  192. Rest of APEJ Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  193. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  194. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  195. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  196. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  197. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  198. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  199. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  200. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  201. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  202. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  203. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  204. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  205. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  206. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gr owth (%), 2018-2028

  207. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  208. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  209. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  210. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%) , 2018-2028

  211. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  212. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  213. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  214. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  215. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  216. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  217. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  218. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  219. APEJ Cell Line Development Market Attractiveness Analysis, By Country 

  220. APEJ Cell Line Development Market Attractiveness Analysis, By Source Type 

  221. APEJ Cell Line Development Market Attractiveness Analysis, By Product Type 

  222. APEJ Cell Line Development Market Attractiveness Analysis, By End User 

  223. APEJ Cell Line Development Market Attractiveness Analysis, By Type of Cell Lines 

  224. Japan Cell Line Development Market Value Share (2017A), By Product Type 

  225. Japan Cell Line Development Market Value Share (2017A), By Source Type 

  226. Japan Cell Line Development Market Value Share (2017A), By End User 

  227. Japan Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  228. Japan Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  229. Japan Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028 

  230. Japan Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2018-2028 

  231. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  232. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  233. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  234. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  235. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  236. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  237. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  238. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  239. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  240. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  241. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  242. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  243. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  244. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gr owth (%), 2018-2028

  245. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  246. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  247. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  248. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%) , 2018-2028

  249. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  250. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  251. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  252. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  253. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  254. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  255. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  256. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  257. Japan Cell Line Development Market Attractiveness Analysis, By Source Type 

  258. Japan Cell Line Development Market Attractiveness Analysis, By Product Type 

  259. Japan Cell Line Development Market Attractiveness Analysis, By End User 

  260. Japan Cell Line Development Market Attractiveness Analysis, By Type of Cell Lines 

  261. Middle East and Africa Cell Line Development Market Value Share, By Country 

  262. Middle East and Africa Cell Line Development Market Value Share (2017A), By Product Type 

  263. Middle East and Africa Cell Line Development Market Value Share (2017A), By Source Type 

  264. Middle East and Africa Cell Line Development Market Value Share (2017A), By End User 

  265. Middle East and Africa Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  266. Middle East and Africa Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  267. Middle East and Africa Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028

  268. Middle East and Africa Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2 018-2028

  269. GCC Countries Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  270. GCC Countries Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  271. South Africa Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  272. South Africa Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  273. Rest of MEA Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  274. Rest of MEA Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2 018-2028

  275. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  276. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  277. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  278. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  279. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  280. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  281. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  282. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  283. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  284. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  285. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  286. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  287. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  288. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gr owth (%), 2018-2028

  289. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  290. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  291. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  292. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%) , 2018-2028

  293. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  294. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  295. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  296. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  297. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  298. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  299. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  300. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  301. Middle East and Africa Cell Line Development Market Attractiveness Analysis, By Country 

  302. Middle East and Africa Cell Line Development Market Attractiveness Analysis, By Source Type 

  303. Middle East and Africa Cell Line Development Market Attractiveness Analysis, By Product Type 

  304. Middle East and Africa Cell Line Development Market Attractiveness Analysis, By End User 

  305. Middle East and Africa Cell Line Development Market Attractiveness Analysis, By Type of Cell L ines

  306. Global Cell Line Development Market Value Share, By Country 

  307. North America Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  308. North America Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  309. Latin America Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-202 7

  310. Latin America Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  311. Europe Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  312. Europe Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2 28

  313. CIS & Russia Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  314. CIS & Russia Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  315. Japan Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  316. Japan Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-20 28

  317. APEJ Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2013-2027 

  318. APEJ Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-202 8

  319. MEA Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  320. MEA Cell Line Development Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  321. Global cell line development Market Attractiveness Analysis, By Region 

  322. Reagent and Media Market Size (US$ Mn) Analysis, 2013-2017 

  323. Reagent and Media Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  324. Equipment Market Size (US$ Mn) Analysis, 2013-2017 

  325. Equipment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  326. Accessories and Consumables Market Size (US$ Mn) Analysis, 2013-2017 

  327. Accessories and Consumables Market Size (US$ Mn) Analysis, 2017-2028 

  328. Global cell line development Market Attractiveness Analysis, By Product 

  329. Mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  330. Mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  331. Non-mammalian Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  332. Non-mammalian Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  333. Global cell line development Market Attractiveness Analysis, By Source 

  334. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Analysis, 2013-2017 

  335. Cell Line Market Size by Biopharmaceutical Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  336. Cell Line Market Size by Contract Research Organizations (US$ Mn) Analysis, 2013-2017 

  337. Cell Line Market Size by Contract Research Organizations (US$ Mn) Forecast Analysis & Y-o-Y Gr owth (%), 2018-2028

  338. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Analysis, 2013-2017 

  339. Cell Line Market Size by Academics and Research Institutes (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028

  340. Cell Line Market Size by Biotechnology Companies (US$ Mn) Analysis, 2013-2017 

  341. Cell Line Market Size by Biotechnology Companies (US$ Mn) Forecast Analysis & Y-o-Y Growth (%) , 2018-2028

  342. Global Cell Line Development Market Attractiveness Analysis, By End User 

  343. Recombinant Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  344. Recombinant Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  345. Hybridomas Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  346. Hybridomas Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  347. Continuous Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  348. Continuous Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  349. Primary Cell Line Market Size (US$ Mn) Analysis, 2013-2017 

  350. Primary Cell Line Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2018-2028 

  351. Global Cell Line Development Market Attractiveness Analysis, By Cell Line 

  352. Global Cell Line Development Market Value Share (2017A), By Product Type 

  353. Global Cell Line Development Market Value Share (2017A), By Source Type 

  354. Global Cell Line Development Market Value Share (2017A), By End User 

  355. Global Cell Line Development Market Value Share (2017A), By Type of Cell Lines 

  356. Global Cell Line Development Market Size (US$ Mn) Analysis, 2013-2017 

  357. Global Cell Line Development Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2028 

  358. Global Cell Line Development Market Y-o-Y growth (%) Comparison, By Country, 2018-2028 

  359. Global cell line development Market Absolute $ Opportunity, 2013–2028